Long-Term Outcomes with Sotorasib in KRAS G12cMutated Advanced NSCLC from the Global Expanded Access Program (EAP) Study-436

被引：0
|
作者：
Novello, S. [1 ]
Maimon, N. [2 ]
Stevenson, J. [3 ]
Petty, W. [4 ]
Ferreira, C. G. [5 ]
Morbeck, I. [5 ]
Zer, A. [6 ]
Bauman, J. [7 ]
Kalmadi, S. [8 ]
Xia, C. [9 ]
Meloni, A. R. [9 ]
Mehta, B. [9 ]
Ardito-Abraham, C. [9 ]
Kormany, W. [9 ]
Awad, M. [10 ]
机构：
[1] Univ Turin, AOU San Luigi, Orbassano, TO, Italy
[2] Sackler Sch Med, Div Oncol, Meir Med Ctr, LungOncol Serv, Rishon Leziyyon, Israel
[3] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[4] Wake Forest Univ, Sch Med, Winston Salem, NC 27101 USA
[5] Oncoclinicas & CO, Med Sci Innovat Res MedSir, Sao Paulo, Brazil
[6] Rabin Med Ctr, Davidoff Canc Ctr, Petah Tiqwa, Israel
[7] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[8] Ironwood Canc & Res Ctr, Chandler, AZ USA
[9] Amgen Inc, Thousand Oaks, CA USA
[10] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.12E.04
引用
收藏
页码：S352 / S353
页数：2
相关论文
共 23 条
  • [1] Sotorasib in KRAS G12C-mutated advanced non-small cell lung cancer (aNSCLC): Overall survival (OS) data from the global expanded access program (EAP study-436)
    Novello, S.
    Maimon, N.
    Stevenson, J. P.
    Petty, W.
    Ferreira, C. G. M.
    Morbeck, I.
    Zer, A.
    Bauman, J. R.
    Kalmadi, S.
    Xia, C.
    Meloni, A.
    Varrieur, T.
    Awad, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S40 - S41
  • [2] Sotorasib in Advanced KRAS p.G12C-Mutated NSCLC with Treated or Untreated Brain Metastases: Safety and Efficacy Data from the Global Expanded Access Program (EAP)
    Awad, M. M.
    Pelizzari, G.
    Stevenson, J.
    Majem, M.
    Ferreira, C. Gil
    Petty, W.
    Arriola, E.
    De Castro, J.
    Morbeck, I.
    Bauman, J.
    Toschi, L.
    Zer, A.
    Metro, G.
    Kalmadi, S.
    Azkarate, A.
    Xia, C.
    Meloni, A.
    Obiozor, C.
    Hsu, H.
    Varrieur, T.
    Ardito-Abraham, C.
    Maimon, N.
    Novello, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E17 - E17
  • [3] Sotorasib in advanced KRAS p.G12C-mutated non-small cell lung cancer (NSCLC): Safety and efficacy data from the global expanded access program (EAP)
    Awad, M.
    Pelizzari, G.
    Stevenson, J. P.
    Majem Tarruella, M.
    Ferreira, C. G. M.
    Petty, W. J.
    Arriola, E.
    de Castro, J.
    Morbeck, I.
    Bauman, J. R.
    Toschi, L.
    Zer, A.
    Metro, G.
    Kalmadi, S.
    Azkarate Martinez, A.
    Xia, C.
    Meloni, A.
    Obiozor, C.
    Maimon, N.
    Novello, S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1005 - S1005
  • [4] Real-World Comparative Effectiveness of Sotorasib vs Docetaxel as 2L/2L+Treatment of KRAS G12cMutated Advanced NSCLC
    Johnson, M. L.
    Younan, D.
    Kent, S.
    Balasubramanian, A.
    Mesa-Frias, M.
    Stollenwerk, B.
    Sylvester, B. E.
    Mehta, B.
    Chia, V.
    Brookhart, M. A.
    Spira, A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S353 - S354
  • [5] Sotorasib in KRAS p.G12C mutated advanced NSCLC: Real-word data from the Italian Expanded Access Program
    Reale, M. L.
    Passiglia, F.
    Brambilla, M.
    Pasello, G.
    Minuti, G.
    Bulotta, A.
    Pizzutilo, P.
    Sini, C.
    Costa, J.
    Roca, E.
    Bria, E.
    Pilotto, S.
    Genova, C.
    Metro, G.
    Citarella, F.
    Bordi, P.
    Russo, A.
    Chiari, R.
    Andrikou, K.
    Novello, S.
    ANNALS OF ONCOLOGY, 2023, 34
  • [6] Sotorasib long-term clinical outcomes in pretreated KRAS G12C-mutated advanced NSCLC: Pooled analysis from the CodeBreaK clinical trials
    Skoulidis, F.
    Li, B. T.
    Hochmair, M. J.
    Govindan, R.
    Vincent, M.
    Van der Wekken, A. J.
    Reguart Aransay, N.
    O'Byrne, K. J.
    Girard, N.
    Griesinger, F.
    Nishio, M.
    Hafliger, S.
    Lindsay, C.
    Reinmuth, N.
    Paulus, A.
    Papakotoulas, P.
    Obiozor, C.
    Nduka, C.
    Wang, Y.
    De Langen, A. J.
    ANNALS OF ONCOLOGY, 2024, 35 : S830 - S831
  • [7] Sotorasib in KRAS G12C-mutated NSCLC: A multicenter real-world experience from the expanded access program in Germany
    Althoff, F. C.
    Stratmann, J. A.
    Doebel, P.
    Hunerlituerkoglu, A. N.
    Frost, N.
    Christopoulos, P.
    Zum Bueschenfelde, C. Meyer
    Alt, J.
    Webendoerfer, M.
    Kaldune, S.
    Tritchkova, G.
    Waller, C. F.
    Braess, J.
    Kopp, H-G.
    Grohe, C.
    Schumann, C.
    Griesinger, F.
    Kuon, J. B.
    Sebastian, M.
    Reinmuth, N.
    ANNALS OF ONCOLOGY, 2023, 34
  • [8] A study on the long-term survivors in an expanded access program (EAP) of gefitinib in China
    Longyun, L.
    Hui, G.
    Wang, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program
    Passiglia, Francesco
    Reale, Maria Lucia
    Lo Russo, Giuseppe
    Pasello, Giulia
    Minuti, Gabriele
    Bulotta, Alessandra
    Galetta, Domenico
    Pelizzari, Giacomo
    Sini, Claudio
    Bria, Emilio
    Roca, Elisa
    Pilotto, Sara
    Genova, Carlo
    Metro, Giulio
    Citarella, Fabrizio
    Chiari, Rita
    Cortinovis, Diego
    Delmonte, Angelo
    Russo, Alessandro
    Tiseo, Marcello
    Cerea, Giulio
    Carta, Annamaria
    Scotti, Vieri
    Vavala, Tiziana
    Brambilla, Marta
    Buffoni, Lucio
    Buosi, Roberta
    Catania, Chiara
    Gori, Stefania
    Grisanti, Salvatore
    Agustoni, Francesco
    Garbo, Edoardo
    Malapelle, Umberto
    Novello, Silvia
    LUNG CANCER, 2024, 187
  • [10] Nivolumab in Advanced Non-Squamous NSCLC Patients with KRAS Mutations: Results from the Italian Expanded Access Program (EAP)
    Ardizzoni, A.
    Bidoli, P.
    Chiari, R.
    Bonomi, L.
    Turci, D.
    Landi, L.
    Toschi, L.
    De Tursi, M.
    Francini, G.
    Giordano, M.
    Alabiso, O.
    De Censi, A.
    Livi, L.
    Berruti, A.
    Minelli, M.
    Ricevuto, E.
    Illiano, A.
    Puppo, G.
    Delmonte, A.
    Galetta, D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1804 - S1804
123